Company news
Venmax Drugs & Pharmaceuticals Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
October 26, 2026
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
October 24, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 28 2026
September 28, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
September 28, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2026
September 26, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
September 26, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 25 2026
September 25, 2026
Closure of Trading Window
September 25, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 08 2026
September 8, 2026
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
September 8, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 01 2026
September 1, 2026
Reg. 34 (1) Annual Report.
September 1, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 31 2026
August 31, 2026
Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
August 31, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 24 2026
August 24, 2026
Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
August 24, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2026
August 8, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
August 8, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 07 2026
August 7, 2026
Statement Of Deviation & Variation
August 7, 2026
Unaudited Financial Results For The Quarter Ended June 30, 2026.
August 7, 2026
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.
August 7, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 01 2026
August 1, 2026
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
August 1, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 29 2026
July 29, 2026
Announcement under Regulation 30 (LODR)-Allotment
July 29, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2026
July 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
July 14, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026
June 27, 2026
Closure of Trading Window
June 27, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026
May 6, 2026
Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
May 6, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026
April 6, 2026
Regulation 31(4) - SAST Disclosure
April 6, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
March 30, 2026
Announcement under Regulation 30 (LODR)-Change in Management
March 30, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 27 2026
March 27, 2026
Board Meeting Outcome for Modification Of Draft Scheme Of Amalgamation
March 27, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 26 2026
March 26, 2026
Closure of Trading Window
March 26, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 23 2026
March 23, 2026
Announcement under Regulation 30 (LODR)-Allotment
March 23, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 09 2026
February 9, 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
February 9, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 12 2026
January 12, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
January 12, 2026
Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 26 2025
December 26, 2025
Closure of Trading Window
December 26, 2025
Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 25 2025
November 25, 2025
Announcement under Regulation 30 (LODR)-Resignation of Director
November 25, 2025